These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. New-onset diabetes after transplantation: a review of recent literature. Balla A; Chobanian M Curr Opin Organ Transplant; 2009 Aug; 14(4):375-9. PubMed ID: 19542891 [TBL] [Abstract][Full Text] [Related]
8. How to identify and manage diabetes mellitus after renal transplantation. Stevens KK; Patel RK; Jardine AG J Ren Care; 2012 Feb; 38 Suppl 1():125-37. PubMed ID: 22348372 [TBL] [Abstract][Full Text] [Related]
9. New onset of diabetes after transplantation - an overview of epidemiology, mechanism of development and diagnosis. Kesiraju S; Paritala P; Rao Ch UM; Sahariah S Transpl Immunol; 2014 Jan; 30(1):52-8. PubMed ID: 24184293 [TBL] [Abstract][Full Text] [Related]
11. Approach to the patient with new-onset diabetes after transplant (NODAT). Lane JT; Dagogo-Jack S J Clin Endocrinol Metab; 2011 Nov; 96(11):3289-97. PubMed ID: 22058376 [TBL] [Abstract][Full Text] [Related]
12. New-onset diabetes after transplantation: risk factors and clinical impact. Räkel A; Karelis AD Diabetes Metab; 2011 Feb; 37(1):1-14. PubMed ID: 21295510 [TBL] [Abstract][Full Text] [Related]
13. Renal resistive index as a new independent risk factor for new-onset diabetes mellitus after kidney transplantation. Mutinelli-Szymanski P; Caille A; Tranquart F; Al-Najjar A; Büchler M; Barbet C; Marlière JF; Gatault P; Réault J; Boin C; Chatelet V; Laouad I; Nivet H; Lebranchu Y; Halimi JM Transpl Int; 2012 Apr; 25(4):464-70. PubMed ID: 22364312 [TBL] [Abstract][Full Text] [Related]
14. KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients. Tavira B; Coto E; Díaz-Corte C; Ortega F; Arias M; Torres A; Díaz JM; Selgas R; López-Larrea C; Campistol JM; Ruiz-Ortega M; Alvarez V; Clin Transplant; 2011; 25(3):E284-91. PubMed ID: 21355884 [TBL] [Abstract][Full Text] [Related]
15. Waist circumference as an independent risk factor for NODAT. Dedinská I; Laca Ľ; Miklušica J; Rosenberger J; Žilinská Z; Galajda P; Mokáň M Ann Transplant; 2015 Mar; 20():154-9. PubMed ID: 25791039 [TBL] [Abstract][Full Text] [Related]
16. Hypomagnesemia and the risk of new-onset diabetes after liver transplantation. Van Laecke S; Desideri F; Geerts A; Van Vlierberghe H; Berrevoet F; Rogiers X; Troisi R; de Hemptinne B; Vanholder R; Colle I Liver Transpl; 2010 Nov; 16(11):1278-87. PubMed ID: 21031543 [TBL] [Abstract][Full Text] [Related]
17. Elevated serum gamma-glutamyltransferase and hypomagnesemia are not related with new-onset diabetes after transplantation. Santos L; Rodrigo E; Piñera C; Robledo C; Palomar R; Gómez-Alamillo C; González-Cotorruelo J; Arias M Transplant Proc; 2010 Oct; 42(8):2914-6. PubMed ID: 20970569 [TBL] [Abstract][Full Text] [Related]
18. Predictors of new onset of diabetes after transplantation in stable renal recipients. Shehab-Eldin W; Shoker A Nephron Clin Pract; 2008; 110(1):c1-9. PubMed ID: 18654089 [TBL] [Abstract][Full Text] [Related]
19. Low serum mannose-binding lectin as a risk factor for new onset diabetes mellitus after renal transplantation. Ibernon M; Moreso F; Moreno JM; Bestard O; Cruzado JM; Grinyó JM; Ricart W; Fernández-Real JM; Serón D Transplantation; 2009 Jul; 88(2):272-8. PubMed ID: 19623025 [TBL] [Abstract][Full Text] [Related]